Inflammatory Markers Are Associated With Risk of Colorectal Cancer and Chemopreventive Response to Anti-Inflammatory Drugs
- 1 March 2011
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 140 (3) , 799-808.e2
- https://doi.org/10.1053/j.gastro.2010.11.041
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studiesCancer Causes & Control, 2010
- Antagonistic Effects of Aspirin and Folic Acid on Inflammation Markers and Subsequent Risk of Recurrent Colorectal AdenomasJNCI Journal of the National Cancer Institute, 2009
- Aspirin Use and Survival After Diagnosis of Colorectal CancerJAMA, 2009
- Nonsteroidal Anti-inflammatory Drug Use After 3 Years of Aspirin Use and Colorectal Adenoma Risk: Observational Follow-up of a Randomized StudyJNCI Journal of the National Cancer Institute, 2009
- Aspirin Dose and Duration of Use and Risk of Colorectal Cancer in MenGastroenterology, 2008
- Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2New England Journal of Medicine, 2007
- Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studiesPublished by Elsevier ,2007
- Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal CancerJAMA, 2005
- A Randomized Trial of Aspirin to Prevent Colorectal AdenomasNew England Journal of Medicine, 2003
- Flexible regression models with cubic splinesStatistics in Medicine, 1989